Jci_page_head_homepage_01 Jci_page_head_homepage_02
Joshua M. Thurman, Danica Ljubanović, Pamela A. Royer, Damian M. Kraus, Hector Molina, Nicholas P. Barry, Gregory Proctor, Moshe Levi, V. Michael Holers
Published in Volume 116, Issue 2
J Clin Invest. 2006; 116(2):357–368 doi:10.1172/JCI24521
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 9
Intact Crry function is necessary to prevent injury to PTECs by alternative pathway components present in mouse serum.

PTECs were incubated with fresh mouse serum in the presence or absence of 5D5, an inhibitory mAb to Crry. When incubated with 5D5, the addition of serum to the PTECs resulted in LDH release by the cells. The addition of control IgG, in contrast, did not injure the cells. The addition of the mAb 1379, a specific inhibitor for factor B of the alternative pathway, prevented the release of LDH by cells incubated with 5D5 and serum. The reactions were conducted with 10 mM EGTA to prevent activation of the classical pathway by the antibody. The experiment was repeated using IgG and Fab fragments of the 5D5 antibody, and LDH release was similar in the 2 groups.